Top Markets
#1 Cortex Cortex +34.29%
#2 Seeker Seeker +17.21%
#3 Official Trump Official Trump +10.59%
#4 peaq peaq +9.63%
#5 EXOD EXOD +9.04%
#6 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +8.12%
#7 Ethena Staked ENA Ethena Staked ENA +6.55%
#8 TDCCP TDCCP +6.19%
#9 Stacks Stacks +4.96%
#10 aelf aelf +4.84%
Coin of the day
Cortex Cortex
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Rang in Aktien #6696
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Aktienkurs
$30.90
Zuletzt synchronisiert: 2026-08-27
Marktkapitalisierung
$1.90B
Veränderung (1 Tag)
1.68%
Veränderung (1 Jahr)
859.63%
Land
US
Handel Damora Therapeutics, Inc. (DMRA)

Kategorie

Healthcare
Dividendenrendite-Verlauf für Damora Therapeutics, Inc. (DMRA)
Dividendenrendite (TTM) von Damora Therapeutics, Inc. (Aktienkürzel: DMRA) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Damora Therapeutics, Inc. (DMRA) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH